PTGX Market Cap & Key Metrics
Protagonist Therapeutics, Inc.
$140.63
+$0.57(+0.41%)
40
Overall
20
Value
40
Tech
60
Quality
Market Cap
$9.06B
Volume
1.27M
52W Range
$62.24 - $160.81
Target Price
$173.00
PTGX market cap is $9.06B. This page lists Protagonist Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
PTGX Key Metrics
- Market cap
- $9.06B
- P/E ratio (current-year EPS estimate)
- 33.32
- EPS estimate, current year
- $4.22
- EPS growth, 3-year
- +7.62%
- Value score
- 20
- Quality score
- 60
- Technical score
- 40
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $46.02M | $434.43M | $60.00M | $26.58M | $27.36M |
| EBITDA | -$128.03M | $280.23M | -$75.64M | -$124.02M | -$123.07M |
| EPS | $-2.05 | $4.47 | $-1.39 | $-2.60 | $-2.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $140.63 | +0.4% | 1.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW